Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations
| Brand name | ATORVASTATIN CALCIUM |
| Generic name | ATORVASTATIN CALCIUM |
| Active ingredient(s) | ATORVASTATIN CALCIUM TRIHYDRATE |
| Distributed by / for | Northwind Pharmaceuticals LLC |
| NDC | 51655-946-52 |
| Full product label | Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-946-52 |
| Recalling firm | Northwind Pharmaceuticals LLC |
| Distribution | Nationwide with the United States |
| Quantity | 99 bottles |
| Recall initiated | 2023-03-16 |
| Report date | 2023-05-03 |
| Recall completed | — |
| Recall number | D-0548-2023 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Indianapolis IN United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗